Aranding, Arjay .
HRN: 26-38-23 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/13/2024
12/20/2024
IV
520mg
Q6h
PCAP-D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes